ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,163Medicare Part D Prescriptions Filled, Including Refills

Rank: 333 out of 3734

$571K Total Retail Price of All Prescriptions

Rank: 537 out of 3734

428 Patients Receiving at Least One Drug in Part D
83%Patients 65 Years and Older
28% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Pennsylvania
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 428 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

16% of this provider’s 428 patients filled at least one prescription for a schedule three drug, compared to an average of 8%.

Risky Drugs to Seniors

1% of this provider’s 10,225 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$47 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

28 is the average number of prescriptions (including refills) per patient, compared to an average of 19.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Pennsylvania
LEVOTHYROXINE SODIUM 658 567 1 2
SIMVASTATIN 528 455 2 1
METOPROLOL SUCCINATE 497 413 3 14
OMEPRAZOLE 476 393 4 4
HYDROCODONE-ACETAMINOPHEN 456 338 S3 5 12
LISINOPRIL 375 350 6 3
FUROSEMIDE 301 252 7 7
ATENOLOL 290 254 8 13
AMLODIPINE BESYLATE 252 237 9 5
CITALOPRAM HBR 234 192 10 16
GLIMEPIRIDE 208 165 11 37
ATORVASTATIN CALCIUM 198 183 12 11
HYDROCHLOROTHIAZIDE 197 194 13 9
METOPROLOL TARTRATE 190 169 14 6
WARFARIN SODIUM 151 150 15 10
PRAVASTATIN SODIUM 144 112 16 15
METFORMIN HCL ER 144 126 16 66
GABAPENTIN 131 90 18 17
ALENDRONATE SODIUM 122 111 19 26
FLUOXETINE HCL 121 87 20 61
TRAZODONE HCL 116 83 21 49
TRIAMTERENE-HCTZ 115 105 22 73
TRAMADOL HCL 109 85 23 20
PANTOPRAZOLE SODIUM 107 82 24 22
ZOLPIDEM TARTRATE 100 92 25 24
METFORMIN HCL 99 90 26 8
NEXIUM 93 85 27 36
POTASSIUM CHLORIDE 91 79 28 19
LIPITOR 91 81 28 90
FAMOTIDINE 84 72 30 60
ALLOPURINOL 83 60 31 33
MELOXICAM 82 62 32 52
LOSARTAN POTASSIUM 82 69 32 21
CARVEDILOL 80 80 34 30
TAMSULOSIN HCL 76 76 35 29
VYTORIN 74 74 36 163
PAROXETINE HCL 71 68 37 59
SYNTHROID 70 49 38 47
LANTUS 69 66 39 54
MECLIZINE HCL 66 56 40 139
ADVAIR DISKUS 66 49 40 35
PREDNISONE 60 51 42 42
MORPHINE SULFATE ER 59 0 S2 43 104
CYMBALTA 59 35 43 67
AMLODIPINE BESYLATE-BENAZEPRIL 58 58 45 56
LOSARTAN-HYDROCHLOROTHIAZIDE 58 52 45 71
CLOPIDOGREL 55 46 47 23
GEMFIBROZIL 54 54 48 114
NOVOLIN 70-30 53 53 49 252
ISOSORBIDE MONONITRATE ER 53 52 49 34
QUINAPRIL HCL 52 52 51 74
RANITIDINE HCL 52 47 51 32
PREMARIN 52 38 R 51 246
FLUTICASONE PROPIONATE 51 37 54 46
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 21, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.